Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C20H27NO |
| Molecular Weight | 297.4345 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 3 / 3 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
OC1=CC2=C(C[C@@H]3[C@@H]4CCCC[C@]24CCN3CC5CC5)C=C1
InChI
InChIKey=NLBUEDSBXVNAPB-DFQSSKMNSA-N
InChI=1S/C20H27NO/c22-16-7-6-15-11-19-17-3-1-2-8-20(17,18(15)12-16)9-10-21(19)13-14-4-5-14/h6-7,12,14,17,19,22H,1-5,8-11,13H2/t17-,19+,20+/m0/s1
| Molecular Formula | C20H27NO |
| Molecular Weight | 297.4345 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 3 / 3 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Aminothiazolomorphinans with mixed κ and μ opioid activity. | 2011-03-24 |
|
| Synthesis and opioid receptor binding affinities of 2-substituted and 3-aminomorphinans: ligands for mu, kappa, and delta opioid receptors. | 2010-01-14 |
|
| In vivo characterization of (-)(-)MCL-144 and (+)(-)MCL-193: isomeric, bivalent ligands with mu/kappa agonist properties. | 2008-10 |
|
| In-vitro investigation of oxazol and urea analogues of morphinan at opioid receptors. | 2007-06-15 |
|
| High-affinity carbamate analogues of morphinan at opioid receptors. | 2007-03-15 |
|
| 10-Ketomorphinan and 3-substituted-3-desoxymorphinan analogues as mixed kappa and micro opioid ligands: synthesis and biological evaluation of their binding affinity at opioid receptors. | 2004-01-01 |
|
| Tolerance to the analgesic effect of buprenorphine, butorphanol, nalbuphine, and cyclorphan, and cross-tolerance to morphine. | 2001 |
|
| Kappa opioid agonists as targets for pharmacotherapies in cocaine abuse. | 2000-03 |
Patents
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:00:22 GMT 2025
by
admin
on
Mon Mar 31 18:00:22 GMT 2025
|
| Record UNII |
U6Z73N36V0
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Preferred Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
224-007-5
Created by
admin on Mon Mar 31 18:00:22 GMT 2025 , Edited by admin on Mon Mar 31 18:00:22 GMT 2025
|
PRIMARY | |||
|
5359966
Created by
admin on Mon Mar 31 18:00:22 GMT 2025 , Edited by admin on Mon Mar 31 18:00:22 GMT 2025
|
PRIMARY | |||
|
U6Z73N36V0
Created by
admin on Mon Mar 31 18:00:22 GMT 2025 , Edited by admin on Mon Mar 31 18:00:22 GMT 2025
|
PRIMARY | |||
|
m4018
Created by
admin on Mon Mar 31 18:00:22 GMT 2025 , Edited by admin on Mon Mar 31 18:00:22 GMT 2025
|
PRIMARY | Merck Index | ||
|
DTXSID50878519
Created by
admin on Mon Mar 31 18:00:22 GMT 2025 , Edited by admin on Mon Mar 31 18:00:22 GMT 2025
|
PRIMARY | |||
|
4163-15-9
Created by
admin on Mon Mar 31 18:00:22 GMT 2025 , Edited by admin on Mon Mar 31 18:00:22 GMT 2025
|
PRIMARY | |||
|
Cyclorphan
Created by
admin on Mon Mar 31 18:00:22 GMT 2025 , Edited by admin on Mon Mar 31 18:00:22 GMT 2025
|
PRIMARY |